COVID-19 and NETs: What We Now Know

Six months into the COVID-19 pandemic, what have we learned about the risks to those living with neuroendocrine cancer? Does a cancer diagnosis or cancer treatment increase a person’s risk for serious illness from COVID-19? 

NETRF Chief Executive Officer Elyse Gellerman sat down with Mark Lewis, MD, oncologist, Intermountain Healthcare, and NETRF Board Member to take a look back and a look forward at pandemic developments.

The discussion offers the latest information on how to protect yourself from COVID-19 during routine activities like grocery shopping, dining out, and managing returns to work or school. 

Staying up-to-date on COVID-19

The COVID-19 outbreak is rapidly changing. Aspects of the content may have changed since it was published. To stay abreast of the situation, follow these trusted resources for the latest information: terms and conditions: This information is not intended as and shall not be relied upon as medical advice. The Neuroendocrine Tumor Research Foundation encourages all users to discuss any information found here with their oncologist, physician, and/or an appropriate qualified health professional.